d-alpha tocopherol has been researched along with Buerger Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VOGELSANG, A | 2 |
| IWAO, H; MASUZAKI, S; NAGAYAMA, M; OKUMA, K; SUENO, Y; UEYAMA, M; YOSHIKAWA, K | 1 |
| Baker, PM; Birkenstock, WE; Dent, DM; Immelman, EJ; Louw, JH; Terblanche, J | 1 |
| Schwarz, D | 1 |
5 other study(ies) available for d-alpha tocopherol and Buerger Disease
| Article | Year |
|---|---|
Alpha tocopherol (vitamin E) in obliterative arterial disease.
Topics: alpha-Tocopherol; Gangrene; Humans; Thromboangiitis Obliterans; Vascular Diseases; Vitamin E | 1951 |
[Medical treatment for disorders of the peripheral circulation].
Topics: Ephedrine; Estradiol Congeners; Estrogens; Iodides; Iodine; Raynaud Disease; Sodium; Thromboangiitis Obliterans; Tolazoline; Vitamin E | 1962 |
Smoking and other factors affecting the conservative management of peripheral vascular disease.
Topics: Adult; Aged; Arteriosclerosis; Cholesterol, Dietary; Diabetes Complications; Exercise Therapy; Female; Foot Diseases; Humans; Male; Middle Aged; Prospective Studies; Smoking; Smoking Prevention; Thromboangiitis Obliterans; Vascular Diseases; Vitamin E | 1975 |
[Medical therapy of obliterating arteriopathies].
Topics: Arteriosclerosis Obliterans; Diabetic Angiopathies; Gangrene; Humans; Inositol; Niacinamide; Pyridoxine; Thromboangiitis Obliterans; Vascular Diseases; Vitamin E | 1969 |
Twenty-four years using alpha-tocopherol in degenerative cardiovascular disease.
Topics: Angina Pectoris; Arteriosclerosis; Cardiac Glycosides; Cardiovascular Diseases; Coronary Disease; Drug Synergism; Heart Failure; Humans; Myocardial Infarction; Thromboangiitis Obliterans; Thrombophlebitis; Vitamin E | 1970 |